Hernando Lopez-Bertoni

11PUBLICATIONS
35CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 08, 2026
Phase Ia Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS Exposure.

|May 13, 2026
High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness.

|Apr 29, 2025
Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survival.

Jack Korleski, Sophie Sall, Kathryn M Luly

|Apr 25, 2025
Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 Cells.

Amanda L Johnson, Harmon S Khela, Jack Korleski

|Jan 11, 2025
miR-217-5p NanomiRs Inhibit Glioblastoma Growth and Enhance Effects of Ionizing Radiation via EZH2 Inhibition and Epigenetic Reprogramming.

Jack Korleski, Sweta Sudhir, Yuan Rui

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

Pageof 2

Frequent Collaborators

4 joint publications

Jordan J Green

4 joint publications

Amanda L Johnson

3 joint publications

Jack Korleski

3 joint publications

Sophie Sall